Latin America - EpiLinks

IMPLEMENTATION OF THE DENGUE “SCREEN AND VACCINATE” STRATEGY

by arnaud debuyzer | 25 May, 2022 | Communication for development, Epidemiology and biology, Logistics and health systems, Scientific communication, Social sciences for public health, Strategic and operational guidelines and tools, Vaccine

A toolkit for country decision makers, program planners and local implementers Based on results of long-term clinical trial data confirming differences in dengue vaccine performance based on prior dengue infection, Sanofi Pasteur proposed an update label for...

WORKSHOP ON DENGUE VACCINATION IN THE CONTEXT OF A TEST-AND-VACCINATE STRATEGY IN BRAZIL

by arnaud debuyzer | 25 May, 2022 | Epidemiology and biology, Strategic and operational guidelines and tools, Vaccine

Regional brainstorming for the development of guidelines for the implementation of the dengue vaccine. The state of Paraná in Brazil has conducted community-based campaigns for dengue vaccination during 2016-2018. Following the new Sanofi Pasteur product label and...

EXPERT MEETING FOR DENGUE VACCINE IMPLEMENTATION IN LATIN AMERICA

by arnaud debuyzer | 25 May, 2022 | Epidemiology and biology, Scientific communication, Vaccine

For a better understanding of the new recommendations for the dengue vaccine implementation. The 6th Expert meeting on dengue vaccine implementation in Latin America was held June 22 and 23 2018 in Lima, Peru. The meeting convened a permanent group of Latin America...

TECHNICAL SUPPORT TO DENGUE VACCINE IMPLEMENTATION: INFORMATION FOR DECISION-MAKING

by arnaud debuyzer | 25 May, 2022 | Epidemiology and biology, Scientific communication, Strategic and operational guidelines and tools, Vaccine

Since December 2015, dengue is a vaccine-preventable disease. What are the key factors to consider for vaccine introduction. The CYD-TDV vaccine (commercial name Dengvaxia®) is a dengue tetravalent vaccine (live attenuated), that has been licensed for the prevention...

EXPERT MEETING ON RAPID DIAGNOSTIC TESTS AND IMPLEMENTATION STRATEGIES FOR THE DENGUE VACCINE